Ignite Creation Date:
2025-12-24 @ 7:03 PM
Ignite Modification Date:
2026-01-01 @ 8:55 AM
Study NCT ID:
NCT02633657
Status:
WITHDRAWN
Last Update Posted:
2021-04-12
First Post:
2015-12-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
Sponsor:
XenoPort, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-19
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-10
First Submit QC Date:
None
Study First Post Date:
2015-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-07
Last Update Post Date:
2021-04-12
Last Update Post Date Type:
ACTUAL